Extra Super Viagra
$ 70,00 – $ 700,00Price range: $ 70,00 through $ 700,00
Famvir
$ 136,00 – $ 285,00Price range: $ 136,00 through $ 285,00
Ezetimibe
$ 47,00 – $ 168,00Price range: $ 47,00 through $ 168,00
Ezetimibe is a specialized medication designed to help individuals effectively manage and lower high cholesterol levels in the blood. It works through a unique mechanism that limits the absorption of cholesterol from the small intestine. This treatment is primarily used to reduce elevated LDL, or “bad” cholesterol, in patients with primary hyperlipidemia. When integrated into a heart-healthy routine, it provides essential support for maintaining balanced lipid profiles and cardiovascular wellness. Ezetimibe can be used as a standalone therapy or in combination with other medications to help reach desired health outcomes.
Active substance: Ezetimibe
SKU:
Ezetimibe
Category: Cholesterol
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Ezetimibe – What You Need to Know
Ezetimibe belongs to a class of lipid-lowering compounds known as cholesterol absorption inhibitors. It is prescribed under federal regulatory guidelines to assist in managing blood lipid levels alongside dietary modifications. Unlike traditional lipid-altering agents that target liver synthesis primarily, this medication selectively inhibits intestinal cholesterol absorption.
As a prescription-only therapy regulated by the FDA in the United States, ezetimibe may be prescribed independently or in combination with other lipid-modifying agents such as HMG-CoA reductase inhibitors (statins). Treatment plans are determined individually by qualified healthcare providers based on patient lipid goals, baseline liver function, and overall cardiovascular risk factors.
| Attribute | Details |
|---|---|
| Active ingredient (INN) | Ezetimibe |
| Therapeutic class | Cholesterol absorption inhibitor |
| Route of administration | Oral |
| Primary purpose | Reduction of elevated total-C, LDL-C, and Apo B in hyperlipidemia |
| Prescription status | Prescription (Rx only) |
| Storage | Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) |
Clinical Overview and Administration
Main uses
Ezetimibe is indicated as an adjunct to diet for the reduction of elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B (Apo B) in patients with primary hyperlipidemia. It is utilized both as monotherapy when statin therapy is considered inappropriate or not tolerated, and as combination therapy alongside an HMG-CoA reductase inhibitor to achieve target lipid reductions. Additionally, ezetimibe is indicated for reducing elevated sitosterol and campesterol levels in patients with homozygous sitosterolemia, as well as managing lipid parameters in individuals with homozygous familial hypercholesterolemia (HoFH) in combination with other lipid-lowering treatments.
How the drug works
Ezetimibe acts at the brush border of the small intestine to selectively inhibit the absorption of dietary and biliary cholesterol and related plant sterols. The molecular target of ezetimibe is the Niemann-Pick C1-Like 1 (NPC1L1) sterol transporter, which plays a pivotal role in the uptake of cholesterol across the intestinal lumen. By inhibiting NPC1L1, ezetimibe reduces the delivery of intestinal cholesterol to the liver. This reduction causes a depletion of hepatic cholesterol stores, leading to an upregulation of hepatic LDL receptors and a subsequent increase in the clearance of LDL cholesterol from the circulation.
Dosing schedule
The standard recommended dosage of ezetimibe for adults and pediatric patients aged 10 years and older is 10 mg orally once daily. The tablet should be swallowed whole and may be administered with or without food at any time of day. When ezetimibe is prescribed concurrently with a bile acid sequestrant (such as cholestyramine), administration must be timed carefully: ezetimibe should be taken at least 2 hours before or at least 4 hours after the bile acid sequestrant to avoid impaired absorption. No dosage adjustment is required for patients with renal insufficiency or mild hepatic impairment.
Practical tips
Establishing a regular daily routine, such as taking the medication at the same time every morning or evening, helps maintain consistent therapy and supports long-term compliance. Patients should continue adhering to a heart-healthy, low-cholesterol diet throughout treatment, as pharmacological therapy is meant to complement nutritional adjustments rather than replace them. Periodic laboratory testing, including lipid panels and liver function tests, is routinely scheduled by healthcare providers to evaluate treatment efficacy and monitor patient safety.
Pharmacokinetics and Safety Profile
How it’s absorbed and eliminated
Following oral administration, ezetimibe is rapidly absorbed and extensively conjugated in the small intestine and liver to a pharmacologically active phenolic glucuronide (ezetimibe-glucuronide). Peak plasma concentrations of ezetimibe-glucuronide occur within 1 to 2 hours, whereas unconjugated ezetimibe achieves peak plasma concentrations between 4 and 12 hours. Both parent compound and active metabolite undergo extensive enterohepatic recycling, contributing to a prolonged systemic presence. The estimated terminal elimination half-life for total ezetimibe (parent plus glucuronide) is approximately 22 hours. Excretion occurs primarily via the biliary route into feces (~78%), with renal excretion accounting for approximately 11% of the administered dose.
Compatibility with other medicines
Co-administration of ezetimibe with bile acid sequestrants significantly decreases the bioavailability of ezetimibe, necessitating separated administration schedules. Concomitant use with fibrates requires caution; gemfibrozil increases systemic exposure to ezetimibe, and co-administration is generally avoided due to elevated risks of cholelithiasis and gallbladder disease. Co-administration with fenofibrate is clinically acceptable but requires monitoring. Cyclosporine can increase plasma concentrations of ezetimibe, and ezetimibe similarly increases cyclosporine exposure; blood levels of cyclosporine must be closely monitored during co-therapy. When combined with statins, patients should be monitored for potential additive muscle-related toxicities.
What to avoid while taking it
Unlike certain other cardiovascular agents, ezetimibe does not exhibit significant clinical interactions with specific dietary components such as grapefruit juice. However, patients are advised to maintain a lipid-lowering diet low in saturated fat and cholesterol. Excessive alcohol consumption should be avoided, particularly when ezetimibe is co-prescribed with a statin, because chronic or heavy alcohol intake increases the potential risk of liver dysfunction and hepatic enzyme elevations.
Precautions and Specific Populations
If you skip a dose
If a patient misses a scheduled dose of ezetimibe, the missed dose should be taken as soon as remembered on that day. However, if it is nearly time for the next scheduled dose, the patient should skip the missed dose and resume the regular daily dosing schedule. Patients must never take two doses at the same time to make up for a missed dose, as doubling doses does not enhance therapeutic efficacy and may increase the risk of untoward effects.
Special populations
The safety and effectiveness of ezetimibe have not been established in pediatric patients under 10 years of age or in pediatric patients with homozygous familial hypercholesterolemia under 10. Ezetimibe should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus; when co-administered with a statin, the pregnancy contraindications of the statin apply. Ezetimibe is not recommended in patients with moderate to severe hepatic impairment due to increased drug exposure. Elderly patients generally demonstrate similar pharmacokinetics and safety profiles compared to younger adults, requiring no routine dosage adjustments based on age alone.
Important precautions
When ezetimibe is co-administered with a statin, routine liver enzyme monitoring (AST and ALT) should be performed prior to initiating therapy and as clinically indicated thereafter. Persistent transaminase elevations exceeding three times the upper limit of normal warrant evaluation and potential discontinuation of co-therapy. Skeletal muscle toxicity, including myopathy and rhabdomyolysis, has been reported; patients should promptly report unexplained muscle pain, tenderness, or weakness, especially if accompanied by malaise or fever. Healthcare prescribers evaluate baseline liver function and renal status before initiating combination lipid therapy in high-risk individuals.
Adverse reactions
In clinical trials, ezetimibe was generally well tolerated, with an adverse event profile comparable to placebo. Common side effects reported during monotherapy include upper respiratory tract infections, diarrhea, arthralgia, and fatigue. When co-administered with a statin, additional side effects such as myalgia, pain in extremities, and elevated hepatic transaminase levels (ALT and AST) may occur at higher frequencies than with statin monotherapy alone. Severe hypersensitivity reactions, including anaphylaxis, angioedema, and erythema multiforme, have been reported rarely in post-marketing surveillance.
| Pros | Cons |
|---|---|
| Distinct mechanism targeting intestinal absorption rather than hepatic synthesis | Requires specific dosing separation from bile acid sequestrants |
| Can be taken with or without food at any time of day | May increase risk of hepatic transaminase elevations when combined with statins |
| Effective as monotherapy or as an add-on to statin regimens | Not recommended for individuals with moderate to severe hepatic impairment |
| Once-daily dosing schedule supports treatment adherence | Requires regular laboratory monitoring of lipid levels and liver function |
Common Questions
Can ezetimibe be taken at any time of day?
Yes, ezetimibe can be taken at any time of day, with or without food, provided it is taken consistently once every 24 hours. However, if you are also taking a bile acid sequestrant, ezetimibe must be taken at least 2 hours before or at least 4 hours after that medication to ensure proper absorption.
How does ezetimibe differ from a statin?
Statins work primarily in the liver by inhibiting HMG-CoA reductase, an enzyme responsible for cholesterol production. Ezetimibe works in the small intestine by blocking the NPC1L1 transporter, which prevents the absorption of cholesterol from food and bile. Because they act through different pathways, doctors sometimes prescribe them together for enhanced lipid reduction.
What should I do if I experience unexplained muscle soreness while taking this medication with a statin?
If you experience unexplained muscle pain, tenderness, weakness, or cramping–especially if accompanied by fatigue or fever–contact your healthcare provider promptly. Muscle symptoms can indicate skeletal muscle toxicity, such as myopathy or rhabdomyolysis, which requires immediate medical assessment and potential adjustment of your treatment plan.
Is routine blood work necessary during treatment with ezetimibe?
Yes, your healthcare provider will periodically order blood tests to evaluate your lipid levels and assess treatment response. When ezetimibe is used in combination with a statin, routine liver function tests (monitoring ALT and AST enzymes) are performed before starting therapy and periodically during treatment to ensure liver safety.
Can I consume alcohol while taking ezetimibe?
Moderate alcohol consumption does not directly interfere with ezetimibe absorption. However, heavy or chronic alcohol use can strain liver function and increase the risk of elevated liver enzymes, particularly when ezetimibe is combined with a statin. Discuss your alcohol intake with your prescriber to ensure safe management.
Information on this page is for reference and does not replace an assessment by a licensed healthcare professional. In accordance with FDA requirements.
Additional information
| Dosage |
10 mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills |
| Ενεργός Ουσία |
Related products
Actigall
$ 60,00 – $ 521,00Price range: $ 60,00 through $ 521,00
Active substance: Ursodiol
More Details
This product has multiple variants. The options may be chosen on the product page
Atorlip 20
$ 74,00 – $ 542,00Price range: $ 74,00 through $ 542,00
Active substance: Atorvastatin
More Details
This product has multiple variants. The options may be chosen on the product page
Crestor
$ 50,00 – $ 435,00Price range: $ 50,00 through $ 435,00
Active substance: Rosuvastatin
More Details
This product has multiple variants. The options may be chosen on the product page
Lasuna
$ 58,00 – $ 244,00Price range: $ 58,00 through $ 244,00
Active substance: extracts of garlic
More Details
This product has multiple variants. The options may be chosen on the product page
Rosuvastatin
$ 66,00 – $ 390,00Price range: $ 66,00 through $ 390,00
Active substance: Rosuvastatin
More Details
This product has multiple variants. The options may be chosen on the product page
Tricor
$ 55,00 – $ 509,00Price range: $ 55,00 through $ 509,00
Active substance: Fenofibrate
More Details
This product has multiple variants. The options may be chosen on the product page
Urso
$ 66,00 – $ 431,00Price range: $ 66,00 through $ 431,00
Active substance: Ursodeoxycholic Acid
More Details
This product has multiple variants. The options may be chosen on the product page
Zetia
$ 51,00 – $ 394,00Price range: $ 51,00 through $ 394,00
Active substance: Ezetimibe
More Details
This product has multiple variants. The options may be chosen on the product page
